LEMAITRE VASCULAR, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 64.03 USD | -0.31% |
|
+1.57% | +12.81% |
| Mar. 12 | Lemaitre Vascular Insider Sold Shares Worth $309,684, According to a Recent SEC Filing | MT |
| Mar. 07 | Lemaitre Vascular Insider Sold Shares Worth $344,925, According to a Recent SEC Filing | MT |
Chart calendar LeMaitre Vascular, Inc.
ae6c02a30a40ffe2573cbc007f472d4._v8rrYMDWuKF2v2eyHPBm7t58FEPfOfpVZTCsHlbt-k.i70dwOFnK9HvlNDa_yeOo_QVpylLSY-cOteRwBoyhKu7rxmV7XUgr_eTzQ~85cd9a308b3245b6dffa962bd99cb136
Upcoming events on LeMaitre Vascular, Inc.
Past events on LeMaitre Vascular, Inc.
| 2024-04-10 11:30 am | Needham Healthcare Conference |
| 2024-03-20 11:15 am | KeyBanc Life Sciences & MedTech Forum |
| 2024-03-19 01:30 pm | Roth Conference |
| 2024-03-14 10:15 am | Barclays Global Healthcare Conference |
| 2024-03-12 | Ex-dividend day |
| 2024-03-12 11:20 am | Oppenheimer Healthcare MedTech & Services Conference |
| 2024-02-27 05:00 pm | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-19 11:00 am | Needham Growth Conference |
| 2023-12-06 10:00 am | Sidoti December Small-Cap Conference |
| 2023-11-29 02:10 pm | Piper Sandler Healthcare Conference |
| 2023-11-14 | Ex-dividend day |
| 2023-11-14 01:50 pm | Stifel Healthcare Conference |
| 2023-11-14 06:00 am | Jefferies London Healthcare Conference |
| 2023-11-01 05:00 pm | Q3 2023 Earnings Call |
| 2023-11-01 04:05 pm | Q3 2023 Earnings Release |
| 2023-09-26 11:40 am | Cantor Global Healthcare Conference |
| 2023-09-13 | Barrington Virtual Fall Investor Conference |
| 2023-08-16 04:00 pm | UBS Genomics 2.0 and MedTech Innovations Summit |
| 2023-08-15 | Ex-dividend day |
Past dividends on LeMaitre Vascular, Inc.
| 2024-03-12 | Quarterly 0.16 USD |
| 2023-11-14 | Quarterly 0.14 USD |
| 2023-08-15 | Quarterly 0.14 USD |
| 2023-05-15 | Quarterly 0.14 USD |
| 2023-03-07 | Quarterly 0.14 USD |
| 2022-11-15 | Quarterly 0.125 USD |
| 2022-08-23 | Quarterly 0.125 USD |
| 2022-05-15 | Quarterly 0.125 USD |
| 2022-03-06 | Quarterly 0.125 USD |
| 2021-11-17 | Quarterly 0.11 USD |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 117 118 -0.24% | 129 127 1.54% | 154 155 -0.12% | 162 162 -0.02% | 193 194 -0.06% | 212 |
|
EBITDA Million USD | Released Forecast Spread | 26,4 28,4 -7.09% | 36,7 35,6 3.08% | 45,8 47,3 -3.22% | 39,0 38,9 0.45% | 45,9 49,0 -6.3% | 56,3 |
|
EBIT Million USD | Released Forecast Spread | 21,2 22,2 -4.42% | 28,8 27,4 5.08% | 36,4 37,1 -1.94% | 29,9 27,7 7.91% | 36,7 36,5 0.62% | 45,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 21,7 22,4 -3.37% | 27,4 26,0 5.32% | 34,3 35,2 -2.69% | 27,5 27,2 1.1% | 39,5 38,8 1.68% | 49,2 |
|
Net income Million USD | Released Forecast Spread | 17,9 18,0 -0.13% | 21,2 20,1 5.57% | 26,9 27,5 -2.22% | 20,6 20,7 -0.07% | 30,1 29,8 1.19% | 37,2 |
|
EPS USD | Released Forecast Spread | 0,88 0,89 -0.59% | 1,04 0,99 5.58% | 1,25 1,28 -2.63% | 0,93 0,93 0% | 1,34 1,32 1.3% | 1,65 |
| Announcement Date | 06/02/20 | 25/02/21 | 24/02/22 | 23/02/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 39,5 39,7 -0.5% | 39,6 38,7 2.35% | 42,1 41,4 1.73% | 39,0 40,1 -2.58% | 41,0 41,0 -0.09% | 47,1 43,5 8.12% | 50,1 48,1 4.19% | 47,4 47,6 -0.35% | 48,9 49,0 -0.24% | 51,5 | 54,3 | 52,0 | 53,9 | 54,9 |
|
EBITDA Million USD | Released Forecast Spread | 10,6 11,5 -7.04% | 10,3 10,5 -1.7% | 11,3 11,6 -2.21% | 8,21 10,6 -22.27% | 9,64 10,0 -3.82% | 9,80 10,2 -3.47% | 12,0 11,5 4.04% | 11,4 11,2 1.78% | 12,8 13,1 -2.75% | 13,3 | 14,8 | 13,8 | 14,4 | |
|
EBIT Million USD | Released Forecast Spread | 8,30 9,01 -7.86% | 7,93 7,91 0.27% | 8,89 7,54 17.85% | 6,15 8,00 -23.1% | 6,97 7,44 -6.39% | 7,87 7,12 10.58% | 9,63 8,77 9.81% | 9,18 8,13 12.92% | 10,2 9,83 3.84% | 10,5 | 11,9 | 11,0 | 11,7 | 11,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 7,91 8,86 -10.74% | 8,00 7,89 1.31% | 5,55 7,37 -24.76% | 6,15 7,94 -22.53% | 7,80 7,44 4.74% | 8,02 7,52 6.61% | 10,3 9,33 10.56% | 9,83 8,91 10.33% | 11,3 10,5 7.34% | 11,5 | 13,2 | 11,9 | 12,6 | 12,6 |
|
Net income Million USD | Released Forecast Spread | 6,18 6,78 -8.89% | 6,04 6,14 -1.63% | 3,52 5,61 -37.35% | 5,46 6,11 -10.74% | 5,63 5,72 -1.59% | 6,04 5,64 7% | 8,10 7,01 15.51% | 7,50 6,74 11.23% | 8,47 8,04 5.3% | 8,70 | 9,84 | 9,09 | 9,64 | 9,58 |
|
EPS USD | Released Forecast Spread | 0,28 0,31 -8.57% | 0,27 0,28 -2.7% | 0,16 0,25 -36.95% | 0,25 0,28 -9.5% | 0,25 0,26 -2.23% | 0,27 0,25 8% | 0,36 0,32 13.51% | 0,33 0,30 9.48% | 0,38 0,35 7.26% | 0,39 | 0,44 | 0,40 | 0,43 | 0,42 |
| Announcement Date | 24/02/22 | 28/04/22 | 28/07/22 | 27/10/22 | 23/02/23 | 02/05/23 | 01/08/23 | 01/11/23 | 27/02/24 | - | - | - | - | - |
| Today 08:00 am | INTEGER HOLDINGS CORPORATION: Q1 2024 Earnings Release |
| Today 04:05 pm | RESMED, INC.: Q3 2024 Earnings Release |
| Today 04:15 pm | EDWARDS LIFESCIENCES CORPORATION: Q1 2024 Earnings Release |
| 2024-04-25 | MGI TECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | SWS HEMODIALYSIS CARE CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-25 | SWS HEMODIALYSIS CARE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-25 | EDAN INSTRUMENTS, INC.: Q1 2024 Earnings Release |
| 2024-04-25 | NANJING VISHEE MEDICAL TECHNOLOGY CO., LTD: Q4 2023 Earnings Release |
| 2024-04-25 | TINAVI MEDICAL TECHNOLOGIES CO.,LTD.: Q4 2023 Earnings Release |
| 2024-04-26 12:55 am | STRATEC SE: Q1 2024 Earnings Release |
Past sector events for LeMaitre Vascular, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- LMAT Stock
- Calendar LeMaitre Vascular, Inc.
